Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enomoto, N.
Right arrow Articles by Chida, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enomoto, N.
Right arrow Articles by Chida, K.
(Chest. 2006;130:22-29.)
© 2006 American College of Chest Physicians

Quantitative Analysis of Fibroblastic Foci in Usual Interstitial Pneumonia*

Noriyuki Enomoto, MD; Takafumi Suda, MD, PhD; Masato Kato, MD; Yusuke Kaida, MD; Yutaro Nakamura, MD, PhD; Shiro Imokawa, MD, PhD; Masaaki Ida, MD and Kingo Chida, MD, PhD

* From the Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Correspondence to: Takafumi Suda, MD, PhD, 1–20-1 Handayama, Hamamatsu, 431-3192, Japan; e-mail: suda{at}hama-med.ac.jp

Abstract

Study objectives: Using semiquantitative scoring methods, several studies have shown that the amount of fibroblastic foci (FF), which are one of the pathologic characteristics in usual interstitial pneumonia (UIP), is a significant prognostic factor of UIP. In those studies, the degree of FF was evaluated semiquantitatively on several scales by a panel of pulmonary pathologists. However, the evaluation was somewhat subjective because interobserver variation was not small. Additionally, these methods are not entirely practical because two or more pathologists are required. In this study, we tried to develop a more quantitative scoring method of FF.

Patients and methods: With a charge-coupled device camera, we made images of lung sections obtained from 15 patients with UIP associated with collagen vascular disease (CVD) [CVD-UIP] and 16 patients with idiopathic pulmonary fibrosis (IPF) [IPF/UIP], and calculated the proportion of FF areas in the target image areas with an image analytic software.

Measurements and results: Our quantitative scoring method enabled us to readily and objectively evaluate the extent of FF as a quantitative percentage of FF area (%FF) score. Interobserver and intraobserver correlations were high in our method (r = 0.877 and r = 0.898, respectively). The quantitative %FF score (± SD) of IPF/UIP patients was 1.67 ± 0.90%, which was significantly higher than that of CVD-UIP patients (0.39 ± 0.24%, p < 0.0001). A Cox proportional hazards model showed that the quantitative %FF score was a significant predictor of survival in UIP patients. The quantitative %FF score had a correlation with scores assessed by the semiquantitative scoring methods previously reported, but patients with the same score assessed by the semiquantitative methods had widely varying scores assessed by our method.

Conclusions: These results suggest that our quantitative scoring method for FF is more objective than the semiquantitative scoring methods previously reported, providing accurate information about the prognosis of patients with UIP.

Key Words: collagen vascular disease • fibroblastic foci • idiopathic interstitial pneumonia • quantitative analysis • usual interstitial pneumonia




This article has been cited by other articles:


Home page
Eur Respir JHome page
V. Cottin
Interstitial lung disease: are we missing formes frustes of connective tissue disease?
Eur. Respir. J., November 1, 2006; 28(5): 893 - 896.
[Full Text] [PDF]


Home page
ChestHome page
R. M. du Bois
Fibroblastic foci: time to be counted?
Chest, July 1, 2006; 130(1): 3 - 5.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.